Best Hypoglycemia Alert Devices & CGMs That Warn of Lows Early (India, 2026)

What should you look for in a hypo-alert CGM?

A hypoglycaemic event (a “hypo”) is a low blood glucose level. The ADA treats any reading under 70 mg/dL (3.9 mmol/L) as clinically important, with Level 2 defined as below 54 mg/dL (3.0 mmol/L); Diabetes UK describes a hypo as usually below 4 mmol/L (about 72 mg/dL). Because a low can happen without obvious symptoms — and overnight lows during sleep are especially easy to miss, with around half of severe hypoglycaemia in type-1 studies occurring overnight — an alert you can rely on matters.

The ADA notes that real-time CGM “can provide alarms that can warn individuals of falling glucose so that they can intervene,” and that CGM can reveal asymptomatic (unnoticed) hypoglycaemia and help identify patterns. When comparing devices, these are the alert features worth checking:

• •A customisable low-glucose threshold, so you can set the level you want to be warned at.
• •Alerts that work overnight, so a nocturnal low during sleep is less likely to be missed.
• •Real-time readings frequent enough to catch a fast-falling glucose — the Vixxa 2, for example, reads every 60 seconds (about 1,440 times a day).
• •Optional predictive alerts that warn before you reach a low (available on some systems).
• •Optional sharing of readings and alerts with a family member or carer via a companion app (available on some systems).

Predictive alerts vs threshold alerts — what’s the difference?

A threshold alert warns you at the moment your glucose crosses a level you have set — for example, a low alert at 70 mg/dL. A predictive alert warns you before you get there, based on the direction and speed of your glucose. Dexcom’s “Urgent Low Soon” is one example: it warns when your glucose is predicted to reach 55 mg/dL (3.1 mmol/L) within about 20 minutes.

Predictive low alerts are an established CGM feature, and they are offered on more than one system — for example, Medtronic’s Guardian range also includes predictive low alerts — so this capability is not unique to any single brand. The GlucoRx Vixxa 2 offers customisable threshold high and low alerts; it does not offer a predictive low alert. If a predictive warning is important to you, weigh that in your choice and discuss the options with your clinician.

What do ADA and NICE say about CGM and hypoglycaemia?

The American Diabetes Association describes real-time CGM as beneficial and recommended for people at high risk of hypoglycaemia, and notes that CGM can reveal asymptomatic hypoglycaemia and help identify patterns and precipitants. In studies, CGM use has been associated with reduced rates of hypoglycaemia — this is population-level trial evidence, not a guaranteed outcome for any individual.

In the UK, NICE guideline NG17 recommends offering adults with type 1 diabetes a choice of real-time or flash CGM, and lists the fear, frequency, awareness and severity of hypoglycaemia among the factors to weigh. These are clinical-body positions, not product promises. A CGM is a monitoring aid, not a treatment: it can alert you when it detects your glucose falling below a level you set — including while you sleep — but it does not prevent or treat low blood sugar. If you experience a low, follow your doctor’s advice and treatment plan. Individual results vary, and this is not a substitute for medical advice.

Frequently Asked Questions